Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Stoke Therapeutics (STOK – Research Report), Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report) and Prestige Consumer Healthcare (PBH – Research Report) with bullish sentiments.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Stoke Therapeutics (STOK)
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Stoke Therapeutics. The company’s shares closed last Monday at $33.96.
According to TipRanks.com, Werber is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Stoke Therapeutics with a $42.00 average price target, implying a 25.1% upside from current levels. In a report released today, Needham also maintained a Buy rating on the stock with a $40.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Structure Therapeutics, Inc. Sponsored ADR (GPCR)
In a report released yesterday, Samantha Semenkow from Citi reiterated a Buy rating on Structure Therapeutics, Inc. Sponsored ADR, with a price target of $100.00. The company’s shares closed last Monday at $56.65, close to its 52-week high of $62.74.
According to TipRanks.com, Semenkow is a 2-star analyst with an average return of
Currently, the analyst consensus on Structure Therapeutics, Inc. Sponsored ADR is a Strong Buy with an average price target of $107.00, which is an 89.1% upside from current levels. In a report issued on March 2, H.C. Wainwright also maintained a Buy rating on the stock with a $114.00 price target.
Prestige Consumer Healthcare (PBH)
William Blair analyst Jon Andersen maintained a Buy rating on Prestige Consumer Healthcare today. The company’s shares closed last Monday at $60.91.
According to TipRanks.com, Andersen is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Prestige Consumer Healthcare with a $76.00 average price target.
